Sort by:

Deutsch-Williams RJ, Xie Y, Rabinowitz Z, Goemans M, Wirapati P, Vinegoni C, Carlson JCT, Pittet M, Weissleder R

Targeting cancer-­ associated fibroblasts for real-­ time intraoperative tumor identification with a spray-­on fluorescent probe
Sci Adv. 2025;11(47):eaeb5810 - PMID: 41259533 - PMCID: PMC12629203 - DOI: 10.1126/sciadv.aeb5810

Qin T, Mattox AK, Campbell JS, Park JC, Shin KY, Li S, Sadow PM, Faquin WC, Micevic G, Daniels AJ, Haddad R, Garris CS, Pittet MJ, Mempel TR, ONeill A, Sartor MA, Pai SI

Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge.
J Clin Invest. 2025;135(6):ePub - PMID: 40091844 - PMCID: PMC11910227 - DOI: 10.1172/JCI181671

Oh J*, Hoelzl J*, Carlson JCT, Bill R, Peterson HM, Faquin WC, Pittet MJ, Pai SI, Weissleder R

Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer
Cell Rep Med. 2025;6(5):102100 - PMID: 40311615 - PMCID: PMC12147904 - DOI: 10.1016/j.xcrm.2025.102100
3 CSV